SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRX is drawing attention after a sharp, high-volume breakout without a confirmed company announcement. Traders attribute the move to possible institutional buying and short covering, while speculation about Anktiva-related regulatory news competes with caution that no new catalyst has been verified.

Select Sector SPDR Trust (The) - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

XLU is drawing attention for a tentative rebound after a steep sector selloff, with traders highlighting unusually heavy call-option activity and signs of firmer bond markets. Bulls see a potential bottom, while others remain cautious because utilities are sensitive to Treasury yields and the rate outlook is unsettled.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Stronger-than-expected quarterly results and a higher adjusted-EBITDA outlook, alongside CorMedixs DaVita agreement for DefenCath, drove attention. Traders welcomed the initial rally but remain divided over whether expanding adoption can offset lower post-TDAPA reimbursement, and many criticized the stock for failing to hold its gains.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Sam Altmans statement that OpenAI remains a close Cerebras partner with deep engagement has sparked a bullish rebound narrative, with traders arguing it counters concerns about OpenAI using Nvidia chips for a newer inference tier. Skeptics still point to upcoming insider share unlocks and selling pressure as risks.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas Phase 3 personalized cancer-vaccine trial with Keytruda met recurrence-free and distant-metastasis-free survival endpoints in melanoma, fueling enthusiasm about the oncology platform and Mercks role in it. Traders are also debating whether the rally fully reflects the opportunity, given that full trial details and broader applicability remain uncertain and Keytruda faces a looming patent cliff.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

DECK is under pressure amid weakness across footwear and consumer-discretionary stocks, with traders pointing to soft consumer-demand concerns, Nike and retailer weakness, and a bearish BMO rating. The community is split between expecting further downside and viewing the selloff as excessive given Deckers cash position, buybacks, and HOKA and UGG brands.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON is gaining attention after revising its Synaptics acquisition to an all-cash deal, easing concerns about share dilution and with the company expecting earlier earnings accretion. Traders broadly welcomed the change, though some remain wary of added debt and integration risks.

Flutter Entertainment Plc engages in the business of online betting and gaming. It operates through the following segments: UK and Ireland, Australia, International, and US. The UK and Ireland segment includes the operations of Sky Betting and Gaming, Paddy Power, Betfair, and tombola. The Australia segment focuses on sports betting services provided to Australian customers online. The International segment relates to poker, casino, rummy, lottery, and sports betting. The US segment includes sports betting, daily fantasy sports, and gaming services. The company was founded in 1988 and is headquartered in New York, NY.

Flutter Entertainment Plc

Flutters steep selloff is drawing attention amid Brazils online-betting ban and wider regulatory concerns, alongside competition from prediction markets and worries about sportsbook profitability. Traders are split between viewing the shares as oversold value and seeing the persistent decline as a warning; the lasting impact of the Brazil measure remains uncertain.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figmas sharp, volatile swings are fueling debate over selling pressure from unlocked insider shares and whether AI tools threaten its design-software business. Bears point to insider sales, stock-based compensation and SaaS-sector weakness, while bulls cite strong growth and AI monetization, along with falling short interest, as reasons for optimism.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA approval of daraxonrasib (RASONQUE) for metastatic pancreatic cancer, supported by pivotal survival results, remains the main catalyst. Traders are bullish on its commercial potential but debate the companys valuation and the drugs price, while emerging resistance concerns add uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TMQ Q3 &#39;26 Earnings Results &amp; Recap

Trilogy Metals reported net income of $200K for the three months ended August 31, 2026, versus a $1.7M net loss in 2025; nine-month net loss was $13.2M versus $7.5M.

Stocktwits

Trilogy Metals Inc

 Q3 '26 Earnings Results & Recap

Trilogy Metals reported net income of $200K for the three months ended August 31, 2026, versus a $1.7M net loss in 2025; nine-month net loss was $13.2M versus $7.5M.

This account has been verified as an official STOCKTWITS representative.